GH Research’s losses persist as it tries to lift FDA hold for GH001
The firm said it is still trying to provide appropriate data to clear an FDA-issued clinical hold on its application for GH001.
The post GH Research’s losses persist as it tries to lift FDA hold for GH001 appeared first on Green Market Report.
